DOCU vs EBS
DocuSign Inc (DOCU) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. EBS currently screens at market cap $416.4M.
Not investment advice. Open the DOCU and EBS stock pages for the full models.
Not investment advice.